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Introduction
Elastic fi  bers play a crucial role in the structural integrity and 
function of various organs (Rosenbloom et al., 1993). The loss of 
elasticity leads to many age-related phenotypes, such as wrinkled 
skin, emphysema, and arteriosclerosis (Pasquali-Ronchetti and 
Baccarani-Contri, 1997; Bailey, 2001). Therapeutic interven-
tion for these age-related changes has not been realized because 
the mechanisms of the development and maintenance of elastic 
fi  bers remain unclear. Elastic fi  bers comprise two distinct com-
ponents: an amorphous core of cross-linked elastin surrounded 
by a peripheral mantle of microfi  brils. In the process of elastic 
fi  ber assembly, elastin precursors (tropoelastin) are deposited 
on microfi  brils, aligned in an orderly way, and cross-linked by 
lysyl oxidase (LOX) enzymes to form mature elastin, which 
confers the elastic properties to elastic fi  bers (Rosenbloom 
et al., 1993). However, the molecular mechanism of this multi-
step process remains largely unknown (Kielty et al., 2002).
Tropoelastin, which is a major constituent of the elastic 
 fi ber, can interact with other tropoelastin molecules and self-
  aggregate at physiological temperatures. Thus, tropoelastins 
undergo a phase transition, which is termed coacervation, from 
soluble monomers to insoluble aggregates (Urry, 1988). In elastic 
fi  ber assembly, coacervation is considered to play a critical role 
through concentrating and aligning tropoelastin before cross-
linking. However, coacervation of tropoelastins alone is not 
 suffi  cient to explain the assembly process and the variable forms 
of elastic fi  bers in different tissues. For fi  brillar deposition of 
tropoelastin, microfi  brils, which are mainly composed of fi  brillin-1 
and -2, are assumed to act as scaffolds, and to direct the mor-
phogenesis of elastic fi  bers. In fact, mice defi  cient in both 
fi  brillin-1 and -2 were recently reported to exhibit impaired 
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lastic ﬁ   bers are required for the elasticity and 
  integrity of various organs. We and others previ-
ously showed that ﬁ  bulin-5 (also called developing 
arteries and neural crest EGF-like [DANCE] or embry-
onic vascular EGF-like repeat–containing protein [EVEC]) 
is indispensable for elastogenesis by studying ﬁ  bulin-5–
deﬁ  cient mice, which recapitulate human aging phenotypes 
caused by disorganized elastic ﬁ  bers (Nakamura, T., P.R. 
Lozano, Y. Ikeda, Y. Iwanaga, A. Hinek, S. Minamisawa, 
C.F. Cheng, K. Kobuke, N. Dalton, Y. Takada, et al. 
2002.  Nature. 415:171–175; Yanagisawa, H., E.C. 
Davis, B.C. Starcher, T. Ouchi, M. Yanagisawa, J.A. 
Richardson, and E.N. Olson. 2002. Nature. 415:168–171). 
However, the molecular mechanism by which ﬁ   blin-5 
  contributes to elastogenesis remains unknown. We report 
that ﬁ  bulin-5 protein potently induces elastic ﬁ  ber as-
sembly and maturation by organizing tro  poelastin and 
cross-linking enzymes onto microﬁ  brils. Deposition of 
ﬁ   bulin-5 on microﬁ   brils promotes coacervation and 
alignment of tropoelastins on microﬁ   brils, and also 
  facilitates cross-linking of tropoelastin by tethering lysyl 
oxidase-like 1, 2, and 4 enzymes. Notably, recombi-
nant ﬁ   bulin-5 protein induced elastogenesis even in 
  serum-free conditions, although elastogenesis in cell cul-
ture has been believed to be serum-dependent. More-
over, the amount of full-length ﬁ   bulin-5 diminishes 
with age, while truncated ﬁ  bulin-5, which cannot pro-
mote elastogenesis, increases. These data suggest that 
ﬁ  bulin-5 could be a novel therapeutic target for elastic 
ﬁ  ber regeneration.
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elastogenesis (Carta et al., 2006), indicating that fi  brillins are 
required for the initial assembly of elastic fi  bers.
The fi  nal cross-linking step is initiated by oxidative de-
amination of tropoelastins, which is catalyzed by LOXs (Kagan 
and Li, 2003). LOXs are copper-containing monoamine oxidases 
secreted by fi  brogenic cells, such as fi  broblasts and smooth 
muscle cells. Five LOX family members have been identifi  ed 
so far: LOX, LOX-like 1 (LOXL1), 2, 3, and 4 (Molnar et al., 
2003). LOX-defi  cient mice were reported to die perinatally 
  because of insuffi  cient cross-linking of elastin and collagens 
(Maki et al., 2002; Hornstra et al., 2003). LOXL1-defi  cient 
mice were reported to live to adulthood, but to have degenerated 
elastic fi  bers, suggesting that LOXL1 is also important for the 
development and/or maintenance of elastic fi  bers (Liu et al., 
2004). Yet, little is known about how LOXs are recruited to 
  catalyze tropoelastins on microfi  brils.
Thus, the elastic fi  ber assembly involves recruitment and 
organized deposition of various molecules, and seems to be 
tightly regulated and fi  nely tuned to achieve the appropriate 
elastic properties in each organ. However, whether there are 
any specifi  c molecules organizing the assembly of elastic fi  ber 
  components remains unknown. Recently, we and others showed 
that the elastic fi  ber assembly process requires fi  bulin-5 (also 
known as developing arteries and neural crest EGF-like [DANCE] 
or embryonic vascular EGF-like repeat–containing protein 
[EVEC]) by thoroughly investigating fi  bulin-5–defi  cient mice 
Figure 1.  Fibulin-5 potently induces elastic 
  ﬁ  ber development and promotes tropoelastin 
coacervation. (A–C) Human skin ﬁ  broblasts were 
cultured in 10% fetal bovine serum–  containing 
medium (A), in serum-free medium (B), and in 
serum-free medium with 8 μg/ml of puriﬁ  ed 
recombinant FLAG-tagged ﬁ  bulin-5 protein (C). 
Cultures were stained with anti-FLAG (top) or 
anti–human elastin (middle) antibody. The 
bottom images were produced by superimposi-
tion of the top and middle images, together 
with DAPI nuclear staining. (D–G) Human skin 
ﬁ  broblasts were cultured in serum-free medium 
with 0, 2, 4, or 8 μg/ml of puriﬁ  ed  FLAG-
tagged recombinant ﬁ  bulin-5 protein, to examine 
the dose-dependency of ﬁ  bulin-5  elastogenic 
activity. Cultures were stained as in A–C. Bars, 
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(Nakamura et al., 2002; Yanagisawa et al., 2002). These mice 
recapitulate human aging phenotypes, such as loose skin, 
 emphysematous lungs, and stiff arteries because of disorganized 
elastic fibers. Fibulin-5 has an Arg-Gly-Asp motif at the 
N-terminal domain and interacts with cell surface integrins, such 
as αvβ5, αvβ3, and α9β1 (Nakamura et al., 1999, 2002). Fibulin-5 
also has tandem arrays of calcium-binding EGF-like domains 
and a characteristic C-terminal fi  bulin domain, and these struc-
tures enable it to interact with several elastic fi  ber components, 
such as elastin (Yanagisawa et al., 2002; Freeman et al., 2005), 
EMILIN (Zanetti et al., 2004), and LOXL1 (Liu et al., 2004). 
Thus, fi  bulin-5 is a good candidate for an organizer of elasto-
genesis that scaffolds elastic fi  ber components in the vicinity 
of cell surfaces. However, the specifi  c role of fi  bulin-5 in elasto-
genesis, whether fibulin-5 can promote elastogenesis, and 
whether there is a correlation of aging-associated alterations of 
fi  bulin-5 with aging phenotypes, remains unknown.
We report that recombinant fi  bulin-5 protein potently 
  induces elastic fi  ber assembly, even in serum-free cell culture, 
without changing the expression of elastic fi  ber components, 
suggesting that fi  bulin-5 serves as an organizer molecule for 
elastogenesis. Fibulin-5 deposits on microfibrils, promotes 
  aggregation of tropoelastin molecules through coacervation, 
and also interacts with LOXL1, 2, and 4, which are enzymes 
that cross-link elastin. We propose a model in which fi  bulin-5 
tethers LOXL enzymes to microfi  brils, thus facilitating aggre-
gation and cross-linking of elastin on microfi  brils. Intriguingly, 
a much lower level of full-length fi  bulin-5, and a higher level of 
a truncated form of fi  bulin-5 were detected in aged mouse loose 
skin than in young mouse skin because of proteolytic cleavage 
of the N-terminal domain. The cleavage of fi  bulin-5 abrogates 
fi  bulin-5–microfi  bril interaction, leading to loss of the elastic 
 fi ber–organizing activity of fi  bulin-5.
Results
Fibulin-5 promotes assembly of elastic 
ﬁ  ber components
To elucidate the molecular role of fi  bulin-5 in elastogenesis, we 
established an in vitro system to evaluate elastic fi  ber assembly, 
using human skin fi  broblast cultures. In the presence of fetal 
bovine serum, skin fi  broblasts developed an abundant mesh-
work of elastic fi  bers, which were stained with antielastin anti-
body (Fig. 1 A), as previously reported (Mecham, 1987). In the 
absence of serum, they did not develop elastic fi  bers (Fig. 1 B). 
Investigation of elastogenic factors has been hampered by the 
Figure 2.  Quantitative PCR analysis in skin ﬁ  broblasts 
  after addition of recombinant full-length ﬁ  bulin-5 or trun-
cated form of ﬁ  bulin-5. Total RNA from skin ﬁ  broblasts was 
extracted 2 d after addition of recombinant proteins in the 
serum-free culture media. cDNA was synthesized and was 
subjected to quantitative real-time PCR for the expression of 
elastin, LOXL1, LOX, ﬁ  brillin-1, -2, and glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) transcripts. A graphic 
presentation of results obtained by real-time PCR is shown. 
Levels of Gapdh transcript were used to normalize cDNA 
levels. The relative amount of PCR product ampliﬁ  ed from 
control ﬁ  broblasts was set at 100. Data are presented as 
triplicates, and the means ± the SD are shown. The prim-
ers used are shown in Table S1, available at http://www.jcb
.org/cgi/content/full/jcb.200611026/DC1.JCB • VOLUME 176 • NUMBER 7 • 2007  1064
serum dependency of elastogenesis in cell culture, as serum 
contains various proteins of known and unknown functions 
(Mecham, 1987). Surprisingly, we found that skin fi  broblasts 
developed an abundant meshwork of elastic fi  bers, even in 
  serum-free media, when they were cultured with purifi  ed re-
combinant fi  bulin-5 protein (Fig. 1 C). Staining with anti-FLAG 
antibody revealed that added fi  bulin-5 protein colocalized with 
elastin. Recombinant fi   bulin-5 protein induced elastic fi  ber 
  assembly in a dose-dependent manner in serum-free medium 
(Fig. 1, D–G). We scarcely detected endogenous fi  bulin-5 in 
  serum-free culture, whereas we detected abundant deposition 
of fi   bulin-5 in serum-containing culture (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200611026/DC1). 
Addition of fi  bulin-5 protein did not affect the mRNA expres-
sion of elastic fi  ber components (e.g., elastin and fi  brillins; Fig. 2), 
indicating that a suffi  cient amount of elastic fi  ber components 
was produced even in serum-free culture, but that they could not 
be organized into elastic fi  bers without the addition of fi  bulin-5 
protein. These data suggest that fi  bulin-5 is not a signaling mol-
ecule that changes gene expression, but an organizer molecule 
that promotes assembly of elastic fi  ber components.
Fibulin-5 promotes coacervation 
of tropoelastin
Tropoelastin, which is the precursor of elastin, can interact with 
other tropoelastin molecules and self-aggregate at physiological 
temperatures through a phase transition termed coacervation 
(Urry, 1988; Vrhovski et al., 1997). Coacervation is considered 
to be an important step before cross-linking of tropoelastin mole-
cules for elastic fi  ber assembly (Urry, 1988; Vrhovski et al., 1997). 
Because fi   bulin-5 can directly interact with tropoelastin 
(Yanagisawa et al., 2002), we examined whether fi  bulin-5 can 
affect the coacervation of tropoelastin. Purifi  ed recombinant 
tropoelastin protein coacervated at 35–40°C, causing the solu-
tion to become turbid (Fig. 3). In the presence of recombinant 
fi   bulin-5 protein, tropoelastin started to coacervate at lower 
temperatures (Fig. 3), suggesting that fibulin-5 promotes co-
acervation of tropoelastin.
The switching of ﬁ  bulin-5 subtypes 
occurs with age, whereas elastic matrices 
are deteriorated
Fibulin-5–defi  cient mice exhibit aging-related characteristics, 
including loose skin, emphysema, and stiff arteries, because of 
disorganized elastic fi  ber development (Nakamura et al., 2002; 
Yanagisawa et al., 2002). Because tissue elastic properties are 
gradually reduced with aging (Pasquali-Ronchetti and Baccarani-
Contri, 1997; Bailey, 2001), we examined the age-related 
changes of elastic matrices by observing skin tissues of young 
and old mice with transmission electron microscopy. As shown 
in Fig. 4 A, elastic fi  bers were disorganized and fragmented in 
old mice, whereas they were organized into thick fi  brous struc-
tures in young mice (Fig. 4 A, middle and top). The deteriorated 
elastic fi  bers in old mice closely resemble the disorganized and 
fragmented elastic fi  bers found even in young fi  bulin-5–  defi  cient 
mice (Fig. 4 A, middle and bottom). Next, we investigated 
whether the expression of fi  bulin-5 is altered during aging, as 
we inferred from the data in the previous sections that suggested 
fi  bulin-5 is not only necessary for elastogenesis but also able to 
promote elastic fi  ber organization. Using skin tissues of young 
and old mice, we performed Western blotting with anti–fi  bulin-5 
antibody (BSYN2473). As shown in Fig. 4 B, we detected two 
specifi  c bands in wild-type mice, while we did not detect any 
band in fi  bulin-5–defi  cient mice. Notably, the intensity of the 
upper bands was considerably decreased in the old mice com-
pared with the young mice (Fig. 4 B, compare lanes 1–3 with 
lanes 4–6). On the other hand, the intensity of the bottom bands 
increased remarkably in the old mice (Fig. 4 B, compare lanes 
1–3 with lanes 4–6). From these results, we hypothesized that 
the switching of fi  bulin-5 subtypes may affect the elastogenic 
activity of fi  bulin-5 and be correlated with the deterioration of 
elastic matrices during aging.
Fibulin-5 is partially cleaved in vitro
Because only one major transcript of fi  bulin-5 was detected by 
Northern blot analysis (Nakamura et al., 1999) and no mRNA 
or EST that would code for a protein  10 kD smaller or larger 
than the major form of fi  bulin-5 protein was found in public 
  databases, the two subtypes of fi  bulin-5 protein we observed were 
not thought to be splice variants, but were rather considered to 
be indicative of posttranslational modifi  cation. To investigate 
this modifi  cation, we transfected an expression vector containing 
fi  bulin-5 cDNA with a signal peptide and a FLAG tag at the 
N terminus into 293T cells. The culture medium of these cells was 
collected and subjected to Western blotting. As shown in Fig. 4 C, 
we detected 2 specifi  c bands of 45 and 55 kD with an anti–fi  bulin-5 
antibody (BSYN2473; Fig. 4 C, left) that recognizes amino 
Figure 3.  Coacervation assay using puriﬁ   ed recombinant tropoelastin 
and ﬁ  bulin-5 proteins. 1 mg/ml of soluble tropoelastin with 0, 4, or 40 
μg/ml of ﬁ  bulin-5 protein was induced to coacervate by increasing the 
temperature, and the turbidity of the solution was measured. Data were 
obtained in duplicate, and the mean ± the SD values are shown.FIBULIN-5/DANCE IS AN ELASTOGENIC ORGANIZER • HIRAI ET AL. 1065
  acids 76–98 (Fig. 4 D, red mark). On the other hand, we de-
tected only one 55-kD band with anti-FLAG antibody (Fig. 4 C, 
right). These results suggest that fi  bulin-5 may be cleaved at 
a more N-terminal position than the recognition site of anti–
 fi bulin-5 antibody (Fig. 4 D). We deduced that the lower 45-kD 
band is the cleaved form of fi  bulin-5, while the upper 55-kD 
band is the full-length fi  bulin-5. The cleaved N-terminal frag-
ment of fi  bulin-5 appears to be easily degraded because we did 
not detect a 10-kD band corresponding to this fragment with 
anti-FLAG antibody.
Fibulin-5 is speciﬁ  cally cleaved 
after arginine at position 77 
by a serine protease
To identify the cleavage site of fi  bulin-5, we stably transfected 
the C-terminal–histidine-tagged expression vector encoding 
fi  bulin-5 cDNA into 293T cells. We purifi  ed recombinant fi  bulin-5 
protein from the conditioned medium of these cells with immo-
bilized metal affi  nity chromatography, and examined the puri-
fi  ed protein by SDS-PAGE. As expected, we detected two bands 
stained with Coomassie blue, and the lower 45-kD band was 
  assumed to be the cleaved form of fi  bulin-5. We sequenced the 
N-terminal end of the lower band using Edman degradation 
(Fig. 5 A, arrow), and determined that fi  bulin-5 is cleaved after 
the arginine at position 77 (Fig. 5 B, top and middle). The upper 
55-kD band was also confi  rmed by protein sequencing to be 
the full-length fi  bulin-5, as the N-terminal sequence coincided 
with the predicted cleavage site after the signal peptide. As 
many proteases are arginine-specifi  c, we examined whether the 
arginine at position 77 is necessary for the cleavage of fi  bulin-5. 
We constructed an expression vector encoding R77A mutant 
fi  bulin-5, which was mutated from arginine to alanine at position 77 
(Fig. 5 B, bottom), and transfected this R77A mutant fi  bulin-5 
vector into 293T cells, followed by Western blotting. As shown 
in Fig. 5 C, we detected only the upper 55-kD band, whereas the 
lower 45-kD band disappeared (lane 2), indicating that the 
R77A mutant fi  bulin-5 is resistant to cleavage. These results 
  indicate that fi  bulin-5 is specifi  cally cleaved after the arginine 
at position 77 (Fig. 5 C, compare lanes 1 and 2), although we 
 cannot rule out the possibility that fi  bulin-5 might not be cleaved 
in vivo at the same site as in vitro cell culture. Next, we examined 
the nature of the protease that cleaves fi  bulin-5. We transiently 
transfected the expression vector encoding C-terminal FLAG-
tagged fi  bulin-5 cDNA into 293T cells, and subsequently added 
different types of protease inhibitors to the culture medium, 
which was subjected to Western blotting. Whereas a cysteine 
protease inhibitor, E64, did not inhibit the cleavage of fi  bulin-5 
at all, a serine protease inhibitor, aprotinin, completely inhibited 
the cleavage (Fig. 5 C, compare lanes 3 and 4). These results 
  indicate that fi  bulin-5 is cleaved by a serine protease in vitro. 
We have not yet succeeded in identifying the serine protease 
that cleaves fi  bulin-5.
Full-length ﬁ  bulin-5 can deposit 
on microﬁ  brils, whereas the truncated 
form of ﬁ  bulin-5 cannot
To assess the functional consequence of fi  bulin-5 cleavage, we 
studied the interaction of fi  bulin-5 and microfi  brils. Microfi  brils, 
Figure 4.  The N-terminal domain cleavage of ﬁ  bulin-5 
is found in aged mouse skin, as well as in cell cultures. 
(A) Fine structure of elastic ﬁ  bers in skin tissues observed 
by transmission electromicroscopy. Elastin was stained 
with tannic acid, and therefore appears as black amor-
phous material. The ﬁ  ne ﬁ  bers surrounding elastin are 
  microﬁ  brils. Bar, 0.4 μm. (B) Skin tissues were harvested 
from wild-type or ﬁ  bulin-5–deﬁ  cient young (3-mo-old) and 
old (22-mo-old) mice. Proteins were extracted from skin 
tissues with 8 M urea and dialyzed against PBS. 10 μg 
each of these extracts were resolved by SDS-PAGE, and 
analyzed by Western blotting with anti–ﬁ  bulin-5 antibody 
(BSYN2473). Two speciﬁ  c bands of 45 and 55 kD were 
detected in wild-type mice with anti–ﬁ  bulin-5  antibody 
(lanes 1–3). The 55-kD band markedly decreased with 
age, whereas the 45-kD band markedly increased with 
age (lanes 4–6). (C) 293T cells were transiently trans-
fected with an expression vector encoding ﬁ  bulin-5 cDNA 
with a signal peptide and a FLAG tag at the N terminus. 
Conditioned medium was subjected to SDS-PAGE, 
followed by Western blotting analysis with either anti–
ﬁ   bulin-5 or anti-FLAG antibody. Two bands of 55 and 
45 kD were detected with anti–ﬁ  bulin-5 antibody, whereas 
only a 55-kD band was detected with anti-FLAG antibody. 
(D) Anti–ﬁ   bulin-5 antibody (BSYN2473) was raised 
against a peptide corresponding to amino acids 76–98 
(red mark). These ﬁ  ndings suggest that ﬁ  bulin-5 is cleaved 
at a more N-terminal position than the recognition site of 
anti–ﬁ  bulin-5 antibody.JCB • VOLUME 176 • NUMBER 7 • 2007  1066
which are mainly composed of fi  brillin-1 and -2, are considered 
to serve as scaffolds for tropoelastin deposition and subsequent 
elastic fi  ber assembly. Fibroblast cell cultures developed fi  ne 
meshworks of fi  brillin-1 microfi  brils, even under serum-free 
conditions, at days 4–7 of culture (Fig. 5, D–F); this is much 
earlier than elastin deposition, which requires >10 d of culture 
in serum-containing medium. When we added recombinant 
 fi bulin-5 protein to the culture, fi  bulin-5 colocalized with 
 fi brillin-1 microfi  brils. However, when we added recombinant 
truncated fi  bulin-5 protein to the culture, the added truncated 
fi  bulin-5 did not deposit on fi  brillin-1 microfi  brils. This was not 
because the truncated form of fi  bulin-5 is susceptible to deg-
radation, as Western blot analysis of the culture medium showed 
that truncated form of fi  bulin-5 was as stable as the full-length 
fi  bulin-5 in the medium (Fig. 5 G). These data indicate that 
full-length fi  bulin-5 can deposit on microfi  brils, whereas the 
truncated form of fi  bulin-5 cannot.
The cleavage of ﬁ  bulin-5 causes inactivation 
of the elastogenic activity of ﬁ  bulin-5
Next, we investigated the consequences of the functional change 
caused by the cleavage of fi  bulin-5 in elastic fi  ber assembly, 
  using the in vitro elastogenesis assay shown in Fig. 1 A with 
 recombinant fi  bulin-5 and the truncated form of fi  bulin-5 proteins. 
Whereas wild-type fi  bulin-5 potently induced elastic fi  ber de-
velopment, the truncated form of fi  bulin-5 did not induce elastic 
fi  ber development at all (Fig. 6, B and C). Therefore, we con-
cluded that the cleavage of fi  bulin-5 causes inactivation of the 
elastogenic activity of fi  bulin-5.
Cross-linking of elastin is promoted 
by prealigned ﬁ  bulin-5 on microﬁ  brils
The assembly of functional elastic fi  bers requires not only 
 fi brillar deposition and coacervation of tropoelastin, but also 
cross-linking of tropoelastin. The aforementioned data suggest 
that deposition of fi  bulin-5 onto microfi  brils accelerates fi  brillar 
tropoelastin deposition, but it was not clear if the tropoelastin 
molecules are cross-linked to form mature functional elastic 
 fi bers. To examine this, we added β-aminopropionitrile (BAPN), 
an irreversible inhibitor of LOXs (Tang et al., 1983), to serum-
free skin fi  broblast culture containing recombinant fi  bulin-5 
protein. It is known that LOXs, which are cross-linking enzymes 
for elastin monomers, are necessary for elastic fi  ber maturation 
(Hornstra et al., 2003; Liu et al., 2004; Maki et al., 2002). As 
shown in Fig. 6 D, elastins showed only a dotlike deposition 
when elastin cross-linking was largely inhibited by BAPN, 
whereas fi  brillar deposition of fi  bulin-5 on microfi  brils was not 
affected by BAPN. This punctuate distribution of elastin is dis-
played by tropoelastin coacervates before cross-linking (Clarke 
et al., 2006). These data indicate that elastic fi  bers organized 
by the addition of fi  bulin-5 protein are cross-linked and mature 
fi  bers, and that not only deposition and aggregation but also 
Figure 5.  Fibulin-5 is cleaved after the arginine at 
position 77 by serine protease and loses the microﬁ  bril-
associating activity. (A) 293T cells were stably transfected 
with an expression vector encoding C-terminal-FLAG– 
and 6× histidine-tagged ﬁ  bulin-5 cDNA. Recombinant 
ﬁ  bulin-5 protein was puriﬁ  ed by chelating chromatog-
raphy from the culture media of these cells, subjected 
to SDS-PAGE, and stained with Coomassie blue. The 
lower band (arrow) was subjected to N-terminal se-
quencing. (B) The N-terminal sequencing of the lower 
band identiﬁ  ed the speciﬁ  c cleavage site of ﬁ  bulin-5 
at the arginine at position 77. (C) 293T cells were 
transiently transfected with the expression vector encod-
ing C-terminal-FLAG– and 6× histidine-tagged ﬁ  bulin-5 
or R77A mutant ﬁ  bulin-5, which had a mutation from 
arginine to alanine at position 77. Transfected cells 
were cultured for 2 d with or without a cysteine prote-
ase inhibitor, E64, or a serine protease inhibitor, apro-
tinine, added to the culture media. Culture media 
were then harvested, concentrated by chelating chro-
matography, and subjected to Western blotting with 
anti-FLAG antibody. (D–G) Human skin ﬁ  broblasts 
were cultured for 4 d in serum-free medium in the pres-
ence of recombinant ﬁ  bulin-5 (D) or recombinant cleaved 
ﬁ  bulin-5 (E) proteins at a concentration of 4 μg/ml in 
the medium, or without recombinant protein (F). The 
cells were then double-stained with anti–ﬁ  brillin-1 
polyclonal antibody (top) and with anti-FLAG mono-
clonal antibody (middle). Bottom images were produced 
by superimposition of the top and middle images, to-
gether with DAPI nuclear staining. Bars, 60 μm. At the 
same time, the conditioned medium was immunoblot-
ted with anti-FLAG antibody to conﬁ  rm that neither 
  ﬁ  bulin-5 nor cleaved ﬁ  bulin-5 was degraded during 
the culture period (G).FIBULIN-5/DANCE IS AN ELASTOGENIC ORGANIZER • HIRAI ET AL. 1067
cross-linking of elastin is promoted by prealigned fibulin-5 
on microfi  brils.
The N-terminal domain-truncated ﬁ  bulin-5 
loses the elastogenic activity, but does not 
interfere with elastic ﬁ  ber assembly
We next examined whether cleaved fi  bulin-5 is merely inactive 
or works against elastogenesis in a dominant-negative manner. 
For this purpose, we quantifi  ed the amount of elastic fi  bers 
  induced by full-length fi  bulin-5 with or without cleaved fi  bulin-5. 
We metabolically labeled newly synthesized elastin with 
[
3H]valine (Keeley, 1976), and measured the incorporation of 
[
3H]valine in the NaOH-insoluble fraction of these cells, which 
refl  ects the amount of mature elastic fi  bers (Hinek et al., 2000). 
As shown in Fig. 6 E, we detected substantial, dose-dependent 
incorporation of [
3H]valine upon adding recombinant fi  bulin-5 
to the medium (Fig. 6 E, compare lanes 1–4). On the other hand, 
cleaved fi  bulin-5 showed neither an additive nor a dominant-
negative effect on fi  bulin-5–induced elastic fi  ber development 
(Fig. 6 E, compare lanes 1–7). These results indicate that   fi  bulin-5 
simply loses its elastogenic activity as a result of cleavage of the 
N-terminal domain.
LOXL1, 2, and 4 proteins mainly interact 
with the C-terminal domain of ﬁ  bulin-5
To develop mature elastic fi  bers, tropoelastin molecules need 
to be highly cross-linked by LOXs. Five LOX family members 
have been identifi  ed so far, LOX, LOXL1, 2, 3, and 4 (Molnar 
et al., 2003). Mice lacking LOX and mice lacking LOXL1 
were recently reported to show profound fragmentation of 
elastic fi  bers (Maki et al., 2002; Hornstra et al., 2003; Liu 
et al., 2004). Moreover, LOXL1 has been reported to interact 
with fi   bulin-5 (Liu et al., 2004). To investigate whether 
 fi bulin-5 interacts with other LOX family members, we per-
formed in vitro binding assays using Myc-tagged LOX and 
LOXLs, and the set of FLAG-tagged fi  bulin-5 deletion mu-
tant   constructs shown in Fig. 7 A. As shown in Fig. 7 B, we 
  detected the specifi  c interaction of LOXL1, 2, and 4 proteins 
with fi  bulin-5 protein (top, lanes 1, 7, and 13). The inter-
action of fi  bulin-5 and these LOXL proteins was eliminated 
or   considerably diminished by the C-terminal deletion of   
fi  bulin-5 (Fig. 7 B, top, lanes 5, 11, and 17). These results in-
dicate that LOXL1, 2, and 4 proteins mainly interact with the 
C-terminal domain of fibulin-5. We also detected substan-
tial, but weak, interaction of fibulin-5 with LOX and LOXL3 
in in vitro binding assays (unpublished data). However, we 
could not determine the specificity of these interactions 
  because all of the fibulin-5 deletion mutants tested seemed 
to weakly interact with LOX or LOXL3. Intriguingly, the 
fibulin-5–LOXL1 interaction was markedly diminished by 
N-terminal deletion of fi  bulin-5 (Fig. 7 B, top left, lanes 2 and 3). 
Thus, fibulin-5 does not interact with LOXL1 after cleavage 
of fibulin-5, and this defect might contribute to the loss of 
 elastogenic  activity.
Figure 6.  Fibulin-5 loses its elastogenic activity upon 
proteolytic cleavage. (A–E) Human skin ﬁ  broblasts were 
cultured in serum-free media without addition of proteins 
(A), with wild-type ﬁ  bulin-5 (B), with the cleaved form of 
ﬁ   bulin-5 (C), or with wild-type ﬁ   bulin-5 and 500 μM 
BAPN (D). Each FLAG-tagged recombinant protein was 
added to the culture at a ﬁ  nal concentration of 4 μg/ml. 
Cultures were stained with anti-FLAG antibody (top) and 
anti–human elastin antibody (middle). The bottom   images 
were produced by superimposition of the top and middle 
images, together with DAPI nuclear staining. Bars, 50 μm. 
(E) Quantitation of insoluble (i.e., cross-linked and mature) 
elastin produced by cells cultured with various amounts 
of wild-type and cleaved ﬁ  bulin-5 added to the medium. 
Cultured skin ﬁ  broblasts were metabolically labeled with 
[
3H]valine during the culture period, and the radioactivity 
of the NaOH-insoluble fractions was quantitated. The 
  radioactivity count was corrected by the relative cell 
  number of separate wells measured with a modiﬁ  ed MTT 
assay, although neither wild-type nor cleaved ﬁ  bulin-5 sig-
niﬁ   cantly affected the cell number (not depicted). Data 
were obtained as quadruplicates, and the mean ± the SD 
is shown.JCB • VOLUME 176 • NUMBER 7 • 2007  1068
Discussion
We have identified an elastic fiber–organizing activity of 
 fi bulin-5/DANCE protein that is abrogated by proteolytic 
cleavage of the N-terminal domain in cell culture and in vivo. 
Our proposed molecular mechanism of elastic fi  ber organization 
by fi  bulin-5/DANCE protein is illustrated in Fig. 8 A. We call 
this the “Line DANCE model.” According to this model, full-
length fi   bulin-5 protein associates with microfi  brils.  Direct 
  interaction of fi  bulin-5 and fi  brillin-1 (Freeman et al., 2005) 
may be important for this association. As fi  bulin-5 serves as 
an integrin ligand through its N-terminal domain (Nakamura 
et al., 1999, 2002), integrin–fi  bulin-5 interaction, in addition 
to integrin–fi  brillin interaction, may help the assembly to  occur 
in the proximity of the cell surface. After fi  bulin-5 interacts 
with microfi  brils, tropoelastins accumulate on fi  bulin-5 proteins 
and coacervate. LOXL enzymes tethered on the C-terminal 
domain of fi  bulin-5 promote cross-linking of the aggregated 
tropoelastins, to form mature elastic fibers. In contrast, as 
  illustrated in Fig. 8 B, the truncated form of fi  bulin-5 cannot 
associate with microfi  brils or integrins, and therefore is un-
able to promote the organization of the elastic fi  ber assembly, 
although the truncated form of fi  bulin-5 itself has the ability to 
bind tropoelastin and enhance coacervation of tropoelastin as 
well (unpublished data).
In this study, we fi  rst succeeded in inducing the develop-
ment of elastic fi  bers in serum-free skin fi  broblast culture 
by adding purifi  ed fi  bulin-5 protein. Tropoelastin and other 
elastic fi  ber components were not organized into elastic fi  bers 
without addition of fi  bulin-5 protein, suggesting that fi  bulin-5 
is not only a necessary component of elastic fi  bers (Nakamura 
et al., 2002; Yanagisawa et al., 2002) but also an organizer 
that can induce elastic fi  ber assembly. Skin fi  broblasts are 
known to develop abundant elastic fi  bers in serum-  containing 
media. However, serum contains various known and unknown 
factors, such as cytokines and growth factors, and also causes 
increases of total cell number and cell density, making it dif-
fi  cult to identify specifi  c molecules that are important for 
elastogenesis. Indeed, we detected a signifi  cant amount of 
fi   bulin-5 in serum using immunoprecipitation and ELISA 
(unpublished data), which might contribute to the elastogenic 
activity of the serum to some extent. We detected abundant 
deposition of fi  bulin-5 that may be derived from fi  broblasts 
or from serum in serum-containing culture of skin fi  bro-
blasts, whereas endogenous fi  bulin-5 was scarcely detected 
in serum-free culture (Fig. S1). This indicates that the dose 
of fi  bulin-5 is crucial for elastic fi  ber organization in this 
 serum-free  cell culture, and that the endogenous expression 
of   fi  bulin-5 alone is insuffi  cient. Our serum-free elastogenesis 
system, in combination with gene knockdown by RNAi, would 
Figure 7.  Fibulin-5 interacts with LOXL enzymes. 
(A) Domain structures of the full-length ﬁ  bulin-5  and 
the ﬁ  bulin-5 deletion mutants used for in vitro binding 
assays. ∆N1-ﬁ  bulin-5 corresponds to the naturally 
cleaved form of ﬁ  bulin-5. These mutants were expressed 
as C-terminal-FLAG–tagged proteins. (B) Fibulin-5 binds 
to LOXL1, 2, and 4 through the C-terminal domain. 
293T cells were transiently transfected with the vectors 
shown in A or a mock vector. Expression vectors for 
Myc-tagged LOX or LOXLs were also independently 
transfected into 293T cells. The conditioned media 
were harvested, and mixed. Each mixture was sub-
jected to immunoprecipitation with anti-FLAG antibody, 
separated by SDS-PAGE, and analyzed by Western 
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be a useful tool to identify other factors that regulate elastic 
fi  ber assembly, as unknown factors in the serum need not be 
taken into account.
It has been reported that fi  bulin-5 can strongly interact 
with tropoelastin (Yanagisawa et al., 2002). We found that 
 fi bulin-5 not only binds with tropoelastin, but also promotes co-
acervation of tropoelastins, and thus plays a more positive role 
in the alignment and deposition of tropoelastin. Fibrillin-1 has 
also recently been reported to promote coacervation (Clarke 
et al., 2005). Because fi  bulin-5 interacts with both fi  brillin-1 
and tropoelastins (Yanagisawa et al., 2002; Freeman et al., 
2005), a fi  bulin-5–fi   brillin-1 complex might cooperatively 
 promote coacervation. Coacervated tropoelastin molecules need 
to be cross-linked by LOX family enzymes for the develop-
ment of mature elastic fi  bers. Our data show that fi  bulin-5 also 
promotes cross-linking of tropoelastin, which may be mediated 
by recruiting LOXL1, 2, and 4 in the vicinity of coacervated 
tropoelastin (Fig. 7 B).
We found that a much higher level of the truncated 
form of fi  bulin-5 was present in aged mouse skin than in 
young mouse skin (Fig. 4 B). There are several possible 
  interpretations of this result: (a) fi  bulin-5 might be cleaved 
because of more protease activity in aged tissues; (b) trun-
cated fi  bulin-5 might be stable and accumulate during life; or 
(c) truncated fi  bulin-5 might be more easily extracted from 
aged elastic fi  bers than from young elastic fi  bers. In any 
case, the truncated form of fi  bulin-5 cannot contribute to new 
elasto  genesis, and therefore the decrease in full-length fi  bulin-5 
may directly refl  ect a decrease in the elastogenic activity of 
aged tissues.
In this study, we could not exclude the possibility that the 
truncated form of fi  bulin-5 might play some roles in elasto-
genesis in vivo. Although truncated fi  bulin-5 cannot contribute to 
new elastogenesis as it cannot interact with microfi  brils, fi  bulin-5 
protein cleaved after deposition onto microfi  brils might take part 
in subsequent processes of elastogenesis, as binding with tro-
poelastin and facilitating coacervation of tropoelastin are not com-
promised by the N-terminal domain cleavage (unpublished data). 
To clarify the physiological consequences of the cleavage of 
fi  bulin-5, further studies will be needed using gene-targeted 
mice in which a cleavage-resistant mutant form of fi  bulin-5 is 
knocked-in.
So far, elastic matrices have been considered to be 
  designed to maintain elastic function for a lifetime (Kielty 
et al., 2002). Elastin is reported to have an exceptionally 
long half-life, and to have a turnover rate which approaches 
our lifespan (Shapiro et al., 1991). On the other hand, elastase 
activity is provoked by exposure to sunlight and by smoking, 
causing degradation of the elastic fi  bers of the skin and lung, 
respectively (Fisher et al., 1996; Hautamaki et al., 1997). 
This implies that elastogenic activity needs to be maintained 
even in the adult tissues to regenerate elastic fi  bers. Indeed, 
we detected a signifi  cant amount of fi  bulin-5 in the serum of 
aged mice (unpublished data), and we and others reported 
that the expression of fi  bulin-5 is up-regulated in some path-
ological conditions, such as in atherosclerotic lesions (Kowal 
et al., 1999; Nakamura et al., 1999; Nguyen et al., 2004), 
lung injury by elastase (Kuang et al., 2003), and pulmonary 
hypertension (Merklinger et al., 2005). The potent elasto-
genic activity of fi  bulin-5 might provide future therapeutic 
applications for aging-associated diseases, such as emphy-
sema and arteriosclerosis, or cosmetic applications for  wrinkled 
skin. Application of fi  bulin-5 might be extended to tissue 
  engineering, to make elastic skin or vessels by using cell 
  cultures. Further studies are needed to examine whether 
  fibulin-5 might improve age-related changes of elastic ma-
trices in vivo.
In summary, we demonstrated the elastic fi  ber organizing 
activity of fi  bulin-5 that is abrogated by age-associated pro-
teolytic cleavage. We demonstrated that the addition of recom-
binant fi  bulin-5 protein induces elastic fi  ber development, and 
that a decrease in full-length fi  bulin-5 caused by proteolytic 
cleavage may contribute to the loss of the elastogenic potential 
in aged elastic tissues. Our fi  ndings might provide a molecular 
pathway to future therapeutic applications of the elastic fi  ber 
organizing activity of fi  bulin-5.
Figure 8.  The Line DANCE model. (A) This model illus-
trates how ﬁ  bulin-5/DANCE promotes ﬁ  brillar deposition 
and cross-linking of tropoelastin molecules on microﬁ  brils 
to promote the development of mature elastic ﬁ  bers. 
(B) Truncated ﬁ  bulin-5 cannot be deposited on microﬁ  brils, 
and therefore cannot promote elastic ﬁ  ber assembly.JCB • VOLUME 176 • NUMBER 7 • 2007  1070
Materials and methods
Cell culture
293T cells and human skin ﬁ  broblasts (HSFs) were maintained in DME 
(Sigma-Aldrich) supplemented with 2 mM glutamine, 10% penicillin/ 
streptomycin, and 10% FBS at 37°C in 5% CO2. HSFs were provided by 
M. Naito (Kyoto University, Kyoto, Japan).
Plasmid construction
Human full-length ﬁ  bulin-5 cDNA was cloned as previously described (Nakamura 
et al., 1999). pEF6/V5 (Invitrogen) was modiﬁ  ed by incorporation of a 
  C-terminal FLAG-tag or Myc-tag (pEF6/FLAG, pEF6/Myc). The ﬁ  bulin-5 ∆N1- 
(∆nt 247–399), ∆N2- (∆nt 247–504), ∆M- (∆nt 505–1,110), and ∆C- (∆nt 1,
114–1,512) ﬁ  bulin-5 cDNAs were subcloned into pEF6/FLAG. Human 
  ﬁ  bulin-5 cDNA sequences are numbered according to GenBank accession 
no. AF112152. Human full-length LOXL1, 2, 3, and 4 cDNAs were obtained 
from IMAGE (available from GenBank under accession no. BC015090, 
BC000594, BC071865, and BC013153, respectively), and subcloned into 
pEF6/Myc. All constructs were conﬁ  rmed by sequencing (ABI Prism 3100).
Protein puriﬁ  cation
pEF6/V5 (Invitrogen) was modiﬁ  ed by incorporation of a C-terminal histidine 
and FLAG-tag. Human wild-type and each mutant ﬁ   bulin-5 cDNA were 
subcloned into pEF6/FLAG-His. The respective stable blasticidin-resistant 
293T cell clones were then obtained by transfection with these expression 
vectors. Recombinant proteins were puriﬁ   ed from the serum-free condi-
tioned medium of stable lines using Ni-NTA metal afﬁ  nity resin (QIAGEN), 
and desalted with a Hi-Trap desalting column (GE Healthcare). Protein 
concentrations were determined with Coomassie Plus-200 Protein Assay 
Reagent (Pierce Chemical Co.). Human tropoelastin cDNA was cloned 
from human skin ﬁ  broblasts by RT-PCR. Of the four splice variants obtained, 
the longest cDNA, which codes one of the splicing variants of the elastin 
gene (ELNc; available from GenBank under accession no. BC035570), 
was subcloned into pTrcHis vector (Invitrogen) and expressed in bacteria, 
followed by protein puriﬁ  cation with Ni-NTA column (GE Healthcare), as 
previously described (Wachi et al., 2005).
In vitro elastogenesis assay and immunoﬂ  uorescence
HSFs were subconﬂ   uently plated on microscope cover glasses (Fisher 
  Scientiﬁ  c). 3 d after plating, culture media were changed to serum-free 
DME/F12 (Sigma-Aldrich), and puriﬁ   ed recombinant ﬁ  bulin-5  proteins 
were added, and the incubation was continued for another 10 d. The cells 
were ﬁ  xed with 100% methanol, and blocked with 2% BSA. The primary 
antibodies used were anti-FLAG M2 monoclonal (1/100; Sigma-Aldrich), 
anti–human elastin polyclonal (1/100; EPC, PR533), anti–human ﬁ  bulin-5 
monoclonal (1/100; 10A), and anti–human ﬁ  brillin-1 polyclonal (1/100; 
EPC, PR217) antibodies. The secondary antibodies used were Alexa Fluor 
488, 546, or 647 anti–rabbit or –mouse IgG (1/100; Invitrogen). After 
staining with DAPI, stained cells were mounted with a Prolong Gold 
  Antifade Kit (Invitrogen). Fluorescence images were sequentially collected 
using a confocal microscope featuring 405-, 488-, 543-, and 633-nm laser 
lines with an open pinhole setting operated by the built-in software; either 
a microscope (LSM510 META; Carl Zeiss MicroImaging, Inc.) with a   
C-Apo 40×/1.2 NA lens (Figs. 1 and 6) or a microscope (FV-1000; Olympus) 
with a UPlanSApo 40×/0.9 NA lens (Figs. 5 and S1). Image ﬁ  les were 
converted to TIFF format using the operating software, merged, linearly 
contrast stretched (with the same setting in each set of experiments) using 
Photoshop CS2 (Adobe), and imported into Illustrator CS2 (Adobe) for 
  assembly. Anti–human ﬁ  bulin-5 monoclonal antibody (10A) was raised by 
Iwaki Co., Ltd. by immunization of ﬁ  bulin-5–deﬁ  cient mice with puriﬁ  ed 
  recombinant human ﬁ  bulin-5 protein.
Coacervation assay
Coacervation of tropoelastin with or without ﬁ  bulin-5 protein was assessed 
using the method described (Clarke et al., 2005). Soluble tropoelastin and 
ﬁ  bulin-5 were prepared in PBS and mixed on ice. Each reaction mixture 
was transferred to an 8-channel quartz cuvette for light scattering measure-
ments at 440 nm. The temperature of a spectrophotometer (UV-1650; 
Shimazu) ﬁ  tted with a heating/cooling block was regulated by a circulat-
ing water bath. All channels were simultaneously cooled and heated in the 
heating/cooling block by the circulating water.
Transfection, in vitro binding assay, and Western blotting
293T cells were transfected using Lipofectamine PLUS (Invitrogen). The 
mixtures of conditioned media were subjected to immunoprecipitation 
with anti-FLAG M2 afﬁ   nity gel (Sigma-Aldrich). After washing, immune 
complexes were resolved by SDS-PAGE, transferred to PVDF mem  branes 
(Bio-Rad Laboratories), and reacted with HRP-conjugated   anti-Myc mono-
clonal (9E10; 1/500; Santa Cruz Biotechnology) or anti-FLAG M2 mono-
clonal (1/1,000; Sigma-Aldrich) antibody. Signals were   detected using 
Western Lightning Chemiluminescence Reagent PLUS (Perkin Elmer).
Tissue extraction and Western blotting
Proteins were extensively extracted from skin tissues with 8 M urea solution. 
After dialysis against PBS, the protein concentration was measured with 
Coomassie Plus-200 Protein Assay Reagent. Protein samples of the same 
amount were subjected to SDS-PAGE (Invitrogen), followed by Western 
blotting with anti–ﬁ  bulin-5 antibody (1/400, BSYN2473). HRP-conjugated 
anti–rabbit antibody (1/2,000; Santa Cruz Biotechnology) was used as a 
secondary antibody.
Transmission electron microscopy
For transmission electron microscopy, skin tissues were ﬁ  xed with 4% 
paraformaldehyde, 2.5% glutaraldehyde, 0.1% tannic acid in 0.1 M 
caco  dylate buffer. Sections were then stained with uranyl acetate.
Quantitative measurement of insoluble elastin
HSFs were subconﬂ  uently plated on 60-mm dishes in quadruplicates. 3 d 
after plating, 20 μCi [
3H]valine was added to each dish, together with 
puriﬁ  ed recombinant ﬁ  bulin-5 protein or cleaved ﬁ  bulin-5 protein. The 
cultures were then incubated at 37°C in 5% CO2 for 10 d. The cells were 
harvested in 0.1 M acetic acid on ice. After centrifugation, the pellets 
were boiled in 0.1 N NaOH for 1 h. Subsequently, the NaOH-  insoluble 
pellets were boiled with 5.7 N HCl for 1 h, mixed with scintillation ﬂ  uid, and 
measured for radioactivity with a scintillation counter (Beckman Coulter).
Reverse transcription-polymerase chain reaction and quantitative PCR
Total RNAs were extracted using RNeasy Plus Mini Kit (QIAGEN) and tran-
scribed to cDNA with random hexamers using the SuperScript III First-
Strand Synthesis System (Invitrogen). For quantitative PCR, the reaction 
was performed with a QuantiTect SYBR Green PCR kit (QIAGEN), and the 
products were analyzed with the Mx3000P QPCR System (Stratagene). 
Primers used for quantitative PCR are provided in Table S1 (available at 
http://www.jcb.org/cgi/content/full/jcb.200611026/DC1).
Online supplemental material
Fig. S1 shows that serum induces ﬁ  bulin-5 deposition on microﬁ  brils. Table S1 
shows primers used for quantitative PCR. The online version of this article is 
available at http://www.jcb.org/cgi/content/full/jcb.200611026/DC1.
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